Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Update

Posted by Tyrone Williams on Jul 31st, 2026

Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 22,725 shares, an increase of 67.9% from the June 30th total of 13,534 shares. Based on an average daily trading volume, of 7,171 shares, the days-to-cover ratio is currently 3.2 days. Currently, 2.1% of the company’s shares are short sold.

Hedge Funds Weigh In On Global X HealthTech ETF

Several hedge funds have recently added to or reduced their stakes in HEAL. Glenmede Investment Management LP bought a new position in Global X HealthTech ETF during the third quarter worth about $31,000. Banque Cantonale Vaudoise bought a new stake in shares of Global X HealthTech ETF in the 3rd quarter valued at about $37,000. EverSource Wealth Advisors LLC increased its stake in shares of Global X HealthTech ETF by 26,522.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock valued at $70,000 after acquiring an additional 2,387 shares during the last quarter. Royal Bank of Canada raised its position in shares of Global X HealthTech ETF by 39.4% in the 1st quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock valued at $62,000 after acquiring an additional 736 shares during the period. Finally, Farther Finance Advisors LLC acquired a new stake in shares of Global X HealthTech ETF in the 4th quarter valued at approximately $111,000.

Global X HealthTech ETF Stock Performance

Shares of Global X HealthTech ETF stock opened at $26.89 on Friday. The firm has a fifty day moving average of $26.72 and a two-hundred day moving average of $26.33. The stock has a market capitalization of $28.50 million, a price-to-earnings ratio of 42.80 and a beta of 1.10. Global X HealthTech ETF has a 52 week low of $23.00 and a 52 week high of $33.59.

About Global X HealthTech ETF

(Get Free Report)

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.